Möchten Sie immer auf dem neuesten Stand bleiben?

ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics sold its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $205...

RENO, Nev., March 31, 2026 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or “the Company”), a pioneer in sustainable battery metals recycling and refining, today announced key...

Not for distribution to U.S. newswire services or for release publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. Any failure to...

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Aldebaran Resources Inc. (“Aldebaran” or the “Company”) (TSX-V: ALDE, OTCQX: ADBRF) announces that it has adopted a shareholder rights...

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Regulus Resources Inc. (“Regulus” or the “Company”, TSX-V: REG, OTCQX: RGLSF) announces that it has adopted a shareholder rights plan...

MIAMI, March 30, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), today announced the closing of...

VANCOUVER, British Columbia, March 30, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — The mining sector is running out of new ground to explore. Global exploration budgets fell to...

Fancamp Exploration Ltd. acquires up to 3% iron ore royalty in Newfoundland and Labrador while advancing a planned 2026 spin-out of its exploration assets

(All dollar amounts are expressed in Canadian dollars, unless stated otherwise) HIGHLIGHTS Q4 2025 (at December 31, 2025) Financial: ~$422.3 million in cash and cash equivalents; sold 3,970...

WILMETTE, Ill., March 27, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Company,” “we”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative...